|
SAP30 |
Sin3A associated protein 30 |
- HDACs deacetylate histones
- NoRC negatively regulates rRNA expression
- Potential therapeutics for SARS
|
|
|
|
SETDB1 |
SET domain bifurcated histone lysine methyltransferase 1 |
- PKMTs methylate histone lysines
|
|
|
|
SIN3A |
SIN3 transcription regulator family member A |
- SUMOylation of transcription cofactors
- Regulation of lipid metabolism by PPARalpha
- NoRC negatively regulates rRNA expression
- RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
- Loss of MECP2 binding ability to 5mC-DNA
- Regulation of MECP2 expression and activity
- MECP2 regulates neuronal receptors and channels
- MECP2 regulates transcription of neuronal ligands
- FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
- Factors involved in megakaryocyte development and platelet production
|
|
|
|
SMAD2 |
SMAD family member 2 |
- Signaling by NODAL
- Signaling by NODAL
- Signaling by Activin
- Downregulation of TGF-beta receptor signaling
- TGF-beta receptor signaling activates SMADs
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- SMAD4 MH2 Domain Mutants in Cancer
- SMAD2/3 MH2 Domain Mutants in Cancer
- TGFBR1 KD Mutants in Cancer
- Transcriptional regulation of pluripotent stem cells
- Ub-specific processing proteases
- FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
- FOXO-mediated transcription of cell cycle genes
- FOXO-mediated transcription of cell cycle genes
|
|
|
|
SMARCA5 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
- NoRC negatively regulates rRNA expression
- B-WICH complex positively regulates rRNA expression
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Deposition of new CENPA-containing nucleosomes at the centromere
|
- Beta-D-Glucose
- 4-Deoxy-Alpha-D-Glucose
|
|
|
SMYD1 |
SET and MYND domain containing 1 |
|
|
|
|
SNW1 |
SNW domain containing 1 |
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Transcription and Translation
- Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
- NOTCH1 Intracellular Domain Regulates Transcription
- NOTCH1 Intracellular Domain Regulates Transcription
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Notch-HLH transcription pathway
- mRNA Splicing - Major Pathway
- RUNX3 regulates NOTCH signaling
- RUNX3 regulates NOTCH signaling
- NOTCH3 Intracellular Domain Regulates Transcription
- NOTCH3 Intracellular Domain Regulates Transcription
- NOTCH4 Intracellular Domain Regulates Transcription
|
|
|
|
SP1 |
Sp1 transcription factor |
- PPARA activates gene expression
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Activation of gene expression by SREBF (SREBP)
- Oncogene Induced Senescence
- RNA polymerase II transcribes snRNA genes
- RNA polymerase II transcribes snRNA genes
- Estrogen-dependent gene expression
|
|
|
|
SP3 |
Sp3 transcription factor |
- SUMOylation of transcription factors
|
|
|
|
SPEN |
spen family transcriptional repressor |
|
|
|
|
SS18L1 |
SS18L1 subunit of BAF chromatin remodeling complex |
|
|
|
|
STAT3 |
signal transducer and activator of transcription 3 |
- Interleukin-6 signaling
- BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
- Interleukin-7 signaling
- Interleukin-7 signaling
- Signaling by SCF-KIT
- Signaling by cytosolic FGFR1 fusion mutants
- Downstream signal transduction
- Signalling to STAT3
- Senescence-Associated Secretory Phenotype (SASP)
- Signaling by Leptin
- POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
- Association of TriC/CCT with target proteins during biosynthesis
- Transcriptional regulation of pluripotent stem cells
- Interleukin-10 signaling
- Interleukin-4 and Interleukin-13 signaling
- PTK6 Activates STAT3
- PTK6 Activates STAT3
- Interleukin-20 family signaling
- MET activates STAT3
- MET activates STAT3
- Interleukin-15 signaling
- Interleukin-35 Signalling
- Interleukin-9 signaling
- Interleukin-37 signaling
- Interleukin-23 signaling
- Interleukin-23 signaling
- Interleukin-27 signaling
- Interleukin-21 signaling
- Transcriptional regulation of granulopoiesis
- Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
- Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
- Signaling by PDGFRA extracellular domain mutants
- Growth hormone receptor signaling
|
|
- Other well-defined immunodeficiency syndromes, including the following seven diseases: Wiskott-Aldrich syndrome; DiGeorge syndrome; Hyper-IgE syndrome; X-linked lymphoproliferative syndrome; Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX); Cartilage-Hair Hypoplasia; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
- Oral cancer
|
|
SUMO2 |
small ubiquitin like modifier 2 |
- Vitamin D (calciferol) metabolism
- SUMO is conjugated to E1 (UBA2:SAE1)
- SUMO is transferred from E1 to E2 (UBE2I, UBC9)
- SUMO is proteolytically processed
- SUMOylation of DNA damage response and repair proteins
- SUMOylation of transcription factors
- SUMOylation of transcription cofactors
- SUMOylation of SUMOylation proteins
- SUMOylation of intracellular receptors
- SUMOylation of intracellular receptors
- SUMOylation of chromatin organization proteins
- SUMOylation of RNA binding proteins
- SUMOylation of DNA replication proteins
- Processing of DNA double-strand break ends
- Formation of Incision Complex in GG-NER
|
|
|
|
SUV39H1 |
suppressor of variegation 3-9 homolog 1 |
- PKMTs methylate histone lysines
- SIRT1 negatively regulates rRNA expression
|
|
|
|
SYK |
spleen associated tyrosine kinase |
- GPVI-mediated activation cascade
- GPVI-mediated activation cascade
- FCGR activation
- FCGR activation
- Regulation of actin dynamics for phagocytic cup formation
- Role of phospholipids in phagocytosis
- DAP12 signaling
- Fc epsilon receptor (FCERI) signaling
- Fc epsilon receptor (FCERI) signaling
- Role of LAT2/NTAL/LAB on calcium mobilization
- Role of LAT2/NTAL/LAB on calcium mobilization
- FCERI mediated MAPK activation
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
- Integrin signaling
- CLEC7A (Dectin-1) signaling
- Dectin-2 family
- Dectin-2 family
- Interleukin-2 signaling
- Regulation of signaling by CBL
- Regulation of signaling by CBL
- FCGR3A-mediated IL10 synthesis
- FCGR3A-mediated phagocytosis
- FLT3 signaling through SRC family kinases
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Staurosporine
- N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide
- Tamatinib
- 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide
- 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide
- Ellagic acid
- Fostamatinib
|
|
|
TFCP2 |
transcription factor CP2 |
|
|
|
|
THRA |
thyroid hormone receptor alpha |
- Nuclear Receptor transcription pathway
|
- Liothyronine
- Levothyroxine
- Dextrothyroxine
- Amiodarone
- Liotrix
- KB-141
- Dronedarone
- Eprotirome
- NRP409
- Thyroid, porcine
|
|
|
THRB |
thyroid hormone receptor beta |
- Nuclear Receptor transcription pathway
- SUMOylation of intracellular receptors
|
- Liothyronine
- Levothyroxine
- Dextrothyroxine
- Amiodarone
- Liotrix
- [3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid
- KB-141
- 2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione
- Tiratricol
- GC-24
- Eprotirome
- MB07811
- Sobetirome
- 1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE
- Thyroid, porcine
|
|
|
TOP2A |
DNA topoisomerase II alpha |
- Transcription of E2F targets under negative control by DREAM complex
- SUMOylation of DNA replication proteins
- SUMOylation of DNA replication proteins
|
- Moxifloxacin
- Amsacrine
- Dexrazoxane
- Valrubicin
- Teniposide
- Epirubicin
- Enoxacin
- Pefloxacin
- Ciprofloxacin
- Trovafloxacin
- Daunorubicin
- Etoposide
- Dactinomycin
- Lomefloxacin
- Doxorubicin
- Norfloxacin
- Ofloxacin
- Idarubicin
- Podofilox
- Mitoxantrone
- Sparfloxacin
- Genistein
- Fleroxacin
- Lucanthone
- Banoxantrone
- SP1049C
- Amonafide
- Elsamitrucin
- 13-deoxydoxorubicin
- RTA 744
- Aldoxorubicin
- ZEN-012
- Amrubicin
- Becatecarin
- Annamycin
- Declopramide
- Finafloxacin
|
|
|
TOP2B |
DNA topoisomerase II beta |
- SUMOylation of DNA replication proteins
|
- Dexrazoxane
- Daunorubicin
- Etoposide
- Dactinomycin
- Phosphoaminophosphonic Acid-Adenylate Ester
- Amonafide
- Technetium Tc-99m ciprofloxacin
- ZEN-012
- Becatecarin
- Declopramide
- 3'-THIO-THYMIDINE-5'-PHOSPHATE
|
|